The global genotyping assay market size is expected to reach USD 87.9 Billion in 2028 and register a revenue CAGR of 22.4%, according to the latest report by Reports and Data. Some key factors such as reduction in prices of DNA sequencing and increasing awareness about personalized medicine are factors driving global market revenue growth.
Genotyping assay is a widely used method for determining DNA sequence and genetic composition by comparing it with other sequences. High efficiency, operational flexibility, and access to multiple parameters in a single testing are some essential features of modern genotyping assays. Market revenue growth is attributed to factors such as increasing funding by governments of various countries to support genotyping assay techniques, rising cases of chronic and genetic diseases across the globe, and high demand for these assays in research and educational institutes.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4827
The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers. The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors. It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships.
Key Companies in the market include:
Thermo Fisher Scientific, Illumina, QIAGEN (Netherlands), Agilent Technologies, Danaher Corporation, Roche Diagnostics (Switzerland), GE Healthcare, Fluidigm Corporation, PerkinElmer, Eurofins Scientific (Luxembourg), Bio-Rad Laboratories, Pacific Biosciences of California, GENEWIZ, and Integrated DNA Technologies.
Market segment analysis:
Product Service Outlook (Revenue, USD Billion, 2018 - 2028)
- Reagents Kits
- Genotyping Services
- Instruments
- Sequencers Amplifiers
- Analyzers
- Bioinformatics
- Software
- Services
Technology Outlook (Revenue, USD Billion, 2018 - 2028)
- PCR
- Real-time PCR
- Digital PCR
- Microarrays
- Sequencing
- NGS
- Pyrosequencing
- Sanger Sequencing
- Capillary Electrophoresis
- Amplified Fragment Length Polymorphism
- Restricted Fragment Length Polymorphism
- Single-stranded Conformation Polymorphism
- MALDI-TOF
- Other Technologies
- Allele-specific Oligonucleotide (ASO) Probes
- Fluorescence In Situ Hybridization (FISH))
Application Outlook (Revenue, USD Billion, 2018 - 2028)
- Pharmacogenomics
- Diagnostic Personalized Medicine
- Agricultural Biotechnology
- Animal Genetics
- Other Applications
- Prenatal Testing
- Human Forensics
- Microbial Genomic Studies
- Aquaculture Breeding Studies
End-Use Outlook (Revenue, USD Billion, 2018 - 2028)
- Pharmaceutical and Biopharmaceutical Companies
- Diagnostic and Research Laboratories
- Academic Institutes
- Other End-use
- Animal and Aqua Genetics Companies
- Greenhouses
- Farms
Regional segmentation comprises of a current and forecast estimation of the market in the key geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa. The report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region.
Regional analysis further covers a country-wise analysis to offer insights into key trends and demands in each major country that might affect the growth of the market in the region.
- North America
- US.
- Canada
- Mexico
- Europe
- Germany
- UK.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA
Key Features of the Global Genotyping Assay Market Report:
- Comprehensive analysis of the key players operating in the market along with their SWOT analysis, their business profiles, business overview, market share, global position, and market value
- Identification and analysis of significant trends and factors driving revenue growth of the market
- Analysis of the competitive landscape along with strategic mergers, expansions, agreements, partnerships, joint ventures, acquisitions, and product launches
- Assessment of each market segment along with their growth trends and market revenue contribution
- Study of the key regions to pinpoint growth potential and study opportunities, threats, limitations, and risks
Thank you for reading our report. Customization of this report is available according to the client’s needs. Please get in touch with us to know more about the customization feature and our team will ensure the report is tailored as per your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
